Search research articles
Contact Us
Filters
Showing results (31-40 of 36) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 36 results.
Molecular Neuropsychiatry
|
March 30, 2018
Improved Scalability of Neuron-Based Phenotypic Screening Assays for Therapeutic Discovery in Neuropsychiatric Disorders
Timothy P Spicer, Christopher Hubbs, Thomas Vaissiere, et al.
Cancer Research
|
January 7, 2014
Bufalin is a potent small-molecule inhibitor of the steroid receptor coactivators SRC-3 and SRC-1
Ying Wang, David M Lonard, Yang Yu, et al.
ACS Chemical Biology
|
September 24, 2015
Selective Targeting of Extracellular Insulin-Degrading Enzyme by Quasi-Irreversible Thiol-Modifying Inhibitors
Samer O Abdul-Hay, Thomas D Bannister, Hui Wang, et al.
Elife
|
July 21, 2016
Small molecule proteostasis regulators that reprogram the ER to reduce extracellular protein aggregation
Lars Plate, Christina B Cooley, John J Chen, et al.
Journal of Medicinal Chemistry
|
March 18, 2025
From DNA-Encoded Library Screening to <b>AM-9747</b>: An MTA-Cooperative PRMT5 Inhibitor with Potent Oral In Vivo Efficacy
Ian Sarvary, Mikkel Vestergaard, Loris Moretti, et al.
Journal of Medicinal Chemistry
|
March 27, 2025
Discovery of AMG 193, an MTA-Cooperative PRMT5 Inhibitor for the Treatment of <i>MTAP</i>-Deleted Cancers
Liping H Pettus, Matthew Bourbeau, Nuria A Tamayo, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 36) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 36 results.
Molecular Neuropsychiatry
|
March 30, 2018
Improved Scalability of Neuron-Based Phenotypic Screening Assays for Therapeutic Discovery in Neuropsychiatric Disorders
Timothy P Spicer, Christopher Hubbs, Thomas Vaissiere, et al.
Cancer Research
|
January 7, 2014
Bufalin is a potent small-molecule inhibitor of the steroid receptor coactivators SRC-3 and SRC-1
Ying Wang, David M Lonard, Yang Yu, et al.
ACS Chemical Biology
|
September 24, 2015
Selective Targeting of Extracellular Insulin-Degrading Enzyme by Quasi-Irreversible Thiol-Modifying Inhibitors
Samer O Abdul-Hay, Thomas D Bannister, Hui Wang, et al.
Elife
|
July 21, 2016
Small molecule proteostasis regulators that reprogram the ER to reduce extracellular protein aggregation
Lars Plate, Christina B Cooley, John J Chen, et al.
Journal of Medicinal Chemistry
|
March 18, 2025
From DNA-Encoded Library Screening to <b>AM-9747</b>: An MTA-Cooperative PRMT5 Inhibitor with Potent Oral In Vivo Efficacy
Ian Sarvary, Mikkel Vestergaard, Loris Moretti, et al.
Journal of Medicinal Chemistry
|
March 27, 2025
Discovery of AMG 193, an MTA-Cooperative PRMT5 Inhibitor for the Treatment of <i>MTAP</i>-Deleted Cancers
Liping H Pettus, Matthew Bourbeau, Nuria A Tamayo, et al.
Page
of 4